The funding, which comes from the Israeli Innovation Authority Grant, will be put towards setting up what SuperMeat claims to be world’s largest high-throughput screening system for identifying and optimizing cultivated meat ingredients, supplemental inputs, and cell scaffolding for cultivated meat production.
The company is working with Thermo Fisher Scientific to support the development and operation of the system.
According to SuperMeat CEO Ido Savir, the system will allow SuperMeat to screen hundreds of thousands of materials every month, helping identify the highest quality ingredients with the lowest costs to accelerate the development and production of cultivated meat.
“The system establishment supported by this grant will allow SuperMeat to leverage the cultivated meat production technology it has built to help reduce costs and provide the cultivated meat industry an open platform for commercialization through its strategic partners globally,” said Savir, who previously told this publication that its goal is to have its first production facility in the US up and running by the second half of 2023.
By optimizing the ingredients for the cell feed media, SuperMeat said it will be able to significantly lower production costs and improve product quality – providing an open standard for cell feed ingredients that can be used by cultivated meat companies around the world as the industry as a whole works to reach commercialization.
